California scientists have created a non-hallucinogenic model of the psychedelic drug ibogaine which they are saying may deal with a number of ailments from melancholy, habit and psychiatric problems to PTSD.

The brand new molecule, named tabernanthalog or TBG, is an artificial analog of ibogaine, which retains all the reported therapeutic advantages with none of the uncomfortable side effects which embody hallucinations but in addition cardiac toxicity. 

Anecdotal proof means that ibogaine can scale ...

By systematically tweaking the structure of the psychedelic compound ibogaine, chemists have created a molecule that may someday find use as a treatment for neuropsychiatric disorders, including depression and addiction. The compound, which the researchers call tabernanthalog, also has a simpler structure than ibogaine, making it easier to synthesize.

Researchers in David E. Olson’s lab at the University of California, Davis have been exploring ...